Ardelyx reported $89.66M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Abbott USD 6.65B 787M Jun/2026
Amgen USD 6.89B 415M Dec/2025
Ardelyx USD 89.66M 24.7M Mar/2026
aTyr Pharma USD 987.07K 797.07K Mar/2026
Corcept Therapeutics USD 162.02M 37.56M Mar/2026
Curis USD 1.14M 8.86M Dec/2025
Sanofi EUR 8.11B 343M Mar/2026
TG Therapeutics USD 171.41M 16.98M Mar/2026
United Therapeutics USD 315.5M 286.6M Dec/2025